BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27333361)

  • 1. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience.
    Roy-Chowdhuri S; Stewart J
    Arch Pathol Lab Med; 2016 Nov; 140(11):1191-1199. PubMed ID: 27333361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the success of next-generation sequencing in cytology specimens.
    Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
    Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
    Roy-Chowdhuri S; Chen H; Singh RR; Krishnamurthy S; Patel KP; Routbort MJ; Manekia J; Barkoh BA; Yao H; Sabir S; Broaddus RR; Medeiros LJ; Staerkel G; Stewart J; Luthra R
    Mod Pathol; 2017 Apr; 30(4):499-508. PubMed ID: 28084342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
    Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
    Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
    Han LM; Khanafshar E; Afshar AR; Calkins SM
    Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
    Al Zoughbi W; Kim D; Alperstein SA; Ohara K; Manohar J; Greco N; Khani F; Robinson BD; Rao RA; Elemento O; Mosquera JM; Siddiqui MT
    Cancer Cytopathol; 2021 Nov; 129(11):874-883. PubMed ID: 33929788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
    Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
    Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.
    Sone M; Arai Y; Sugawara S; Kubo T; Itou C; Hasegawa T; Umakoshi N; Yamamoto N; Sunami K; Hiraoka N; Kubo T
    Ups J Med Sci; 2019 Apr; 124(2):119-124. PubMed ID: 31179853
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
    Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
    Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing of cytologic preparations: An analysis of quality metrics.
    Hwang DH; Garcia EP; Ducar MD; Cibas ES; Sholl LM
    Cancer Cytopathol; 2017 Oct; 125(10):786-794. PubMed ID: 28727266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
    da Cunha Santos G; Saieg MA
    Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.
    Zheng G; Tsai H; Tseng LH; Illei P; Gocke CD; Eshleman JR; Netto G; Lin MT
    Am J Clin Pathol; 2016 May; 145(5):696-702. PubMed ID: 27247373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
    Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
    PLoS One; 2018; 13(4):e0196556. PubMed ID: 29702695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Validation of Cytology Specimens for Next-Generation Sequencing and Clinical Practice Experience.
    Balla A; Hampel KJ; Sharma MK; Cottrell CE; Sidiropoulos N
    J Mol Diagn; 2018 Nov; 20(6):812-821. PubMed ID: 29981866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.
    Vigliar E; Malapelle U; de Luca C; Bellevicine C; Troncone G
    Cytopathology; 2015 Oct; 26(5):271-83. PubMed ID: 26399861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing in cytology specimens for molecular profiling of lung adenocarcinoma.
    Zhang Y; Li J; Hua P; Liu N; Li Q; Zhu X; Jiang L; Zheng K; Su X
    Int J Clin Exp Pathol; 2018; 11(7):3647-3655. PubMed ID: 31949745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.